Upstream Bio Corp (UPB) - Biznesning o‘zini qoplash muddati
Upstream Bio Inc (UPB) immunologik agentlarni ishlab chiqishning ilk bosqichlarida bo'lib, bu uning moliyaviy barqarorligi tashqi moliyalashtirishga bog'liqligini anglatadi. Ushbu GURU.Markets grafigida ko'rsatilganidek, kompaniyaning normallashtirilgan P/E ko'rsatkichi joriy parametr -1.30 ekanligini ko'rsatmoqda. Aktivning narx dinamikasi verekimabning xavfsizligi va FDA tasdig'iga bog'liq, umumiy strategiya esa og'ir yallig'lanishga qarshi kurashish uchun molekulalarning tasdiqlanishiga tayanadi.
Upstream Bio Inc kompaniyasining tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Upstream Bio Inc|UPB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Upstream Pharma|UPB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Upstream Bio Inc|UPB - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Upstream Bio|Kritik likvidlik koeffitsiyenti upstreambio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
UPB - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi Upstream Bio Inc|UPB - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Upstream Bio, Inc.|UPB - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Upstream Bio Inc|UPB - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Upstream Bio|UPB - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi upstreambio.com|UPB - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Upstream Bio Inc
Kompaniyaning jamlanma tahlili:UPB (upstreambio.com)
P/E koeffitsiyenti sof foydaning bir birligi qiymatini belgilaydi, bu esa investorga investitsiyalarning qoplanish muddatini va aktiv uchun haddan tashqari to'lov miqdorini baholash imkonini beradi. Upstream Bio Inc (UPB) biotexnologiya startapining joriy narx-foyda nisbatini tahlil qilishda klinik ishlab chiqish bosqichini hisobga olish muhimdir, chunki ichki ishlab chiqarishning yo'qligi ushbu metrikani kelgusi dori vositalariga bo'lgan bozor kutuvlarining ko'rsatkichiga aylantirib, aktivning spekulyativ barqarorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
ARGX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BNTX|Biznesning o‘zini qoplash muddati ABIVAX|Narxning foydaga nisbati ADMA Bio ADMA|PTGX - Narx-foyda koeffitsiyenti|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|GRFS (Grifols) - Narx-foyda koeffitsiyenti|Adaptive Biotech (ADPT) - P/E multiplikatori|Narxning foydaga nisbati Celldex|Narx-foyda multiplikatori AUPH (Aurinia Corp)|P/E multiplikatori BCRX|VERA - Kapitalizatsiyaning foydaga nisbati|Dianthus Therapeutics, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Pharvaris NV PHVS|ABCL - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TRML|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|PHAR - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NKTR|ZBIO (Zenas Bio) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Immunome Corp (IMNM)|GOSS (Gossamer Bio Corp.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori KALV (KalVista Pharmaceuticals)|septerna.com (SEPN) - Kapitalizatsiyaning foydaga nisbati|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti AnaptysBio Inc.|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RAPT|Narxning foydaga nisbati JBIO (aerovatetx.com)|P/E multiplikatori ACRS (Aclaris)|Biznesning o‘zini qoplash muddati Kyverna Therapeutics, Inc (KYTX)|TLSA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati cabalettabio.com|VTYX (Ventyx Biosciences, Inc.) - Narx-foyda koeffitsiyenti|Theratechnologies, Inc. - Kompaniya qiymatining sof foydaga nisbati|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|Eledon Pharmaceuticals, Inc (ELDN) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Agenus (AGEN)|climbbio.com - Narx-foyda multiplikatori|P/E multiplikatori ZURA (Zura Bio)|ATYR - Narx-foyda koeffitsiyenti|ADAG: Narx-foyda koeffitsiyenti|IMA - P/E multiplikatori|shattucklabs.com (STTK) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati EQ (Equillium)|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Narxning foydaga nisbati IMUX|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|Kompaniya qiymatining sof foydaga nisbati ACET|Celularity Corp - P/E multiplikatori|INMB - P/E multiplikatori|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati SAB Biotherapeutics|Narx-foyda koeffitsiyenti akaritx.com (AKTX)|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|GeoVax Labs Inc - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati EDSA|iBio, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati Carisma Therapeutics CARM|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|P/E multiplikatori aditxt.com (ADTX)|Narxning foydaga nisbati GRI Bio GRI|XRTX: Narx-foyda multiplikatori|ReShape Lifesciences - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Revelation Biosciences Corp|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|scinai.com (SCNI) - P/E multiplikatori|Narxning foydaga nisbati CalciMedica Inc|Affimed Therapeutics - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Biznesning o‘zini qoplash muddati hookipapharma.com|IGM Biosciences - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ITOS (iteostherapeutics.com)|OCEA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD: P/E multiplikatori
